Fu YX - Search Results

1

NQO1 targeting prodrug triggers innate sensing to overcome checkpoint blockade resistance.

Li X, Liu Z, Zhang A, Han C, Shen A, Jiang L, Boothman DA, Qiao J, Wang Y, Huang X, Fu YX. Li X, et al. Among authors: fu yx. Nat Commun. 2019 Jul 19;10(1):3251. doi: 10.1038/s41467-019-11238-1. Nat Commun. 2019. PMID: 31324798 Free PMC article.

2

B lymphocytes induce the formation of follicular dendritic cell clusters in a lymphotoxin alpha-dependent fashion.

Fu YX, Huang G, Wang Y, Chaplin DD. Fu YX, et al. J Exp Med. 1998 Apr 6;187(7):1009-18. doi: 10.1084/jem.187.7.1009. J Exp Med. 1998. PMID: 9529317 Free PMC article.

3

Complementary effects of TNF and lymphotoxin on the formation of germinal center and follicular dendritic cells.

Wang Y, Wang J, Sun Y, Wu Q, Fu YX. Wang Y, et al. Among authors: fu yx. J Immunol. 2001 Jan 1;166(1):330-7. doi: 10.4049/jimmunol.166.1.330. J Immunol. 2001. PMID: 11123309

4

Priming of naive T cells inside tumors leads to eradication of established tumors.

Yu P, Lee Y, Liu W, Chin RK, Wang J, Wang Y, Schietinger A, Philip M, Schreiber H, Fu YX. Yu P, et al. Among authors: fu yx. Nat Immunol. 2004 Feb;5(2):141-9. doi: 10.1038/ni1029. Epub 2004 Jan 4. Nat Immunol. 2004. PMID: 14704792 Free article.

5

NK-cell activation by LIGHT triggers tumor-specific CD8+ T-cell immunity to reject established tumors.

Fan Z, Yu P, Wang Y, Wang Y, Fu ML, Liu W, Sun Y, Fu YX. Fan Z, et al. Among authors: fu ml, fu yx. Blood. 2006 Feb 15;107(4):1342-51. doi: 10.1182/blood-2005-08-3485. Epub 2005 Oct 13. Blood. 2006. PMID: 16223768 Free PMC article.

6

Targeting the primary tumor to generate CTL for the effective eradication of spontaneous metastases.

Yu P, Lee Y, Wang Y, Liu X, Auh S, Gajewski TF, Schreiber H, You Z, Kaynor C, Wang X, Fu YX. Yu P, et al. Among authors: fu yx. J Immunol. 2007 Aug 1;179(3):1960-8. doi: 10.4049/jimmunol.179.3.1960. J Immunol. 2007. PMID: 17641063 Free PMC article.

7

B and T lymphocyte attenuator tempers early infection immunity.

Sun Y, Brown NK, Ruddy MJ, Miller ML, Lee Y, Wang Y, Murphy KM, Pfeffer K, Chen L, Kaye J, Fu YX. Sun Y, et al. Among authors: fu yx. J Immunol. 2009 Aug 1;183(3):1946-51. doi: 10.4049/jimmunol.0801866. Epub 2009 Jul 8. J Immunol. 2009. PMID: 19587015 Free PMC article.

8

Cetuximab-mediated tumor regression depends on innate and adaptive immune responses.

Yang X, Zhang X, Mortenson ED, Radkevich-Brown O, Wang Y, Fu YX. Yang X, et al. Among authors: fu yx. Mol Ther. 2013 Jan;21(1):91-100. doi: 10.1038/mt.2012.184. Epub 2012 Sep 18. Mol Ther. 2013. PMID: 22990672 Free PMC article.

9

Type I interferon response and innate immune sensing of cancer.

Fuertes MB, Woo SR, Burnett B, Fu YX, Gajewski TF. Fuertes MB, et al. Among authors: fu yx. Trends Immunol. 2013 Feb;34(2):67-73. doi: 10.1016/j.it.2012.10.004. Epub 2012 Oct 31. Trends Immunol. 2013. PMID: 23122052 Free PMC article. Review.

10

CD47 blockade triggers T cell-mediated destruction of immunogenic tumors.

Liu X, Pu Y, Cron K, Deng L, Kline J, Frazier WA, Xu H, Peng H, Fu YX, Xu MM. Liu X, et al. Among authors: fu yx. Nat Med. 2015 Oct;21(10):1209-15. doi: 10.1038/nm.3931. Epub 2015 Aug 31. Nat Med. 2015. PMID: 26322579 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

596 results

Search Page

Filters